HIV/AIDS in the People's Republic of China
Pay more attention to silent killers
IPN Opinion article
HIV/AIDS is a high profile disease that has received a disproportionately high amount of funding and attention, relative to "silent killers" such as pneumonia and diarrhoea
Drowning a single illness in cash will do more harm than good
IPN Opinion article
Donors are beginning to realise that spending disproportionate sums on AIDS is undermining overall primary healthcare.
AIDS: Away With Political Correctness
IPN Opinion article
The biennial AIDS conference ended in Mexico on 8 August with calls for more money and promises to spend it better but UC Berkeley's James Chin explains why much of that money will be wasted until the AIDS industry honestly accepts the facts: by targetting general populations at extremely low risk, AIDS programs are wasting money that should be spent on high-risk groups.
A false threat of epidemics
IPN Opinion article
UNAIDS has at last admitted its world AIDS estimates were wildly inaccurate but it wanted yet more money at the biennial jamboree in Mexico (3-8 August). In an apparently unconnected development it is also looking for a new Director so this British health systems consultant has decided to throw his hat in the ring on a platform of closing down UNAIDS in order to allocate funds according to the real impact of diseases.
Myths behind AIDS might lead to billions in misspending
IPN Opinion article
Global and regional HIV rates have remained stable or have been decreasing during the past decade except in sub-Saharan Africa; HIV continues to be concentrated in populations with the highest levels of HIV risk behaviors; and HIV is incapable of epidemic spread in the vast majority of heterosexual populations. Let's face the data and put the money where the real problems really are.
"Romantic" AIDS cause diverts needed funds
IPN Opinion article
AIDS advocacy has taken money from diseases that kill more people and are easily cured: we need to redress the balance for the benefit of all poor countries and poor patients. Although average global prevalence is much lower, this imbalance applies even in South Africa and other African countries hard-hit by AIDS.
